Title of Invention | "AN ORGANOMAGNESIUM COMPOUND" |
---|---|
Abstract | The present invention is related to an organomagnesium compound having the general formula wherein n is 1 or 2; R1 is a substituted or unsubstituted C4-C24 heteroaryl, containing one or more heteroatoms as B, O, N, S, Se, P, F, CI, Br, I, or Si; linear or branched, substituted or unsubstituted C1-C20 alkyl, C2-C20 or C2-C20 alkinyl; or substituted or unsubstituted C3-C20 cycloalkyl; or derivative thereof; X and Y are independently or both CI, Br or I, preferably CI; HalOn (Where n=3, 4); carboxylate of formula RCO2; alkoxide or phenoxide of formula RO; dialkoxide of formula LiO-R-O; disilazide of formula (R3Si)2N; thiolate of formula SR; RP(0)02; or SCOR; where R is defined as R1 above; linear or branched, substituted or unsubstituted C1-C20 alkyl or C3-C20 cycloalkyl amine of formula RNH; dialkyl/arylamine of formula R2N (where R is defined as above or R2N represents a heterocyclic alkylamine); phosphine of formula PR2 (where R is defined as above or PR2 represents a heterocyclic phosphine); OnSR (where n=2 or 3 and R is defined as above); or NOn (where n=2 or 3); or X = R1 as defined above; and a derivative thereof. |
Full Text | We Claim: 1. An organomagnesium compound having the general formula (Formula Removed) wherein n is 1 or 2; R1 is a substituted or unsubstituted C4-C24 aryl or C3-C24 heteroaryl, containing one or more heteroatoms as B, O, N, S, Se, P, F, CI, Br, I, or Si; linear or branched, substituted or unsubstituted C1-C20 alkyl, C2-C20 alkenyl or C2-C20 alkinyl; or substituted or unsubstituted C3-C20 cycloalkyl; or derivative thereof; X and Y are independently or both CI, Br or I, preferably CI; HalOn (Where n=3, 4); carboxylate of formula RCO2; alkoxide or phenoxide of formula RO; dialkoxide of formula LiO-R-O; disilazide of formula (R3Si)2N; thiolate of formula SR; RP(O)O2; or SCOR; where R is defined as R1 above; linear or branched, substituted or unsubstituted C1-C20 alkyl or C3-C20 cycloalkyl amine of formula RNH; dialkyl/arylamine of formula R2N (where R is defined as above or R2N represents a heterocyclic alkylamine); phosphine of formula PR2 (where R is defined as above or PR2 represents a heterocyclic phosphine); OnSR (where n=2 or 3 and R is defined as above); or NOn (where n=2 or 3); or X = R1 as defined above; and a derivative thereof. 2. The compound as claimed in claim 1, wherein the compound is (R1)2Mg-LiY 3. The compound as claimed in claim 1, wherein the compound comprises R1(MgX)n and LiY in a molar ratio of 0,05-6,0. 4. The compound as claimed in claim 1-3, wherein Y is CI, tert-butylate or sec-butylate. 5. The compound as claimed in one or more of claims 1 or 3, 4, which is i-PrMgCI-LiCI or sec-BuMgCI-LiCI, in a molar ratio between i-PrMgCI or sec-BuMgCI and LiCI of 0,05 to 6,0. 6. The organomagnesium compound as claimed in claim 1, whenever used in the preparation of organometallic compounds and their reaction with electrophiles. |
---|
849-DEL-2005-Abstract-(18-05-2011).pdf
849-DEL-2005-Claims-(18-05-2011).pdf
849-DEL-2005-Correspondence Others-(05-05-2011).pdf
849-DEL-2005-Correspondence-Others-(18-05-2011)..pdf
849-DEL-2005-Correspondence-Others-(18-05-2011).pdf
849-DEL-2005-Correspondence-Others-(25-03-2010).pdf
849-del-2005-correspondence-others.pdf
849-del-2005-description (complete).pdf
849-DEL-2005-Drawings-(18-05-2011).pdf
849-DEL-2005-Form-1-(18-05-2011).pdf
849-DEL-2005-Form-2-(18-05-2011).pdf
849-DEL-2005-Form-3-(18-05-2011).pdf
849-DEL-2005-GPA-(18-05-2011).pdf
849-DEL-2005-Petition-137-(18-05-2011).pdf
Patent Number | 248652 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Indian Patent Application Number | 849/DEL/2005 | |||||||||
PG Journal Number | 31/2011 | |||||||||
Publication Date | 05-Aug-2011 | |||||||||
Grant Date | 01-Aug-2011 | |||||||||
Date of Filing | 01-Apr-2005 | |||||||||
Name of Patentee | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN | |||||||||
Applicant Address | GESCHWISTER-SCHOLL-PLATZ I, D-80539 MUNCHEN, GERMANY. | |||||||||
Inventors:
|
||||||||||
PCT International Classification Number | C07B 213/00 | |||||||||
PCT International Application Number | N/A | |||||||||
PCT International Filing date | ||||||||||
PCT Conventions:
|